MECHANISMS OF QUINOLONE RESISTANCE IN CLINICAL ISOLATES - ACCUMULATION OF SPARFLOXACIN AND OF FLUOROQUINOLONES OF VARIOUS HYDROPHOBICITY, AND ANALYSIS OF MEMBRANE-COMPOSITION

被引:28
作者
DENIS, A [1 ]
MOREAU, NJ [1 ]
机构
[1] CNRS,CERCOA,BP 28,F-94320 THIAIS,FRANCE
关键词
D O I
10.1093/jac/32.3.379
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
The accumulation of sparfloxacin and three other fluoroquinolones of decreasing hydrophobicity, pefloxacin, ofloxacin, and ciprofloxacin, into randomly chosen fluoroquinolone-sensitive and -resistant clinical isolates of bacteria (four Enterobacteriaceae, one Pseudomonas aeruginosa and one Staphylococcus aureus) was measured. There was good correlation between the concentration of drug that inhibited early DNA synthesis in whole cells and the MIC values of the same drug regardless of organism sensitivity or the quinolone. A decrease in permeability in resistant strains compared with sensitive, due to a modification of outer membrane proteins was often involved in resistance. But, in all cases other mutations may also be involved explaining the relatively high level of resistance of the strains. In two resistant strains the DNA gyrase was purified and found to be resistant to inhibition by quinolones. The use of quinolones of differing hydrophobicity emphasized the importance of this property in the uptake of quinolones by bacterial cells, and provided evidence that sparfioxacin used both porin and the self-promoted uptake pathway for it's uptake. © 1993 The British Society for Antimicrobial Chemotherapy.
引用
收藏
页码:379 / 392
页数:14
相关论文
共 52 条
  • [1] CLINICAL ISOLATE OF CITROBACTER-FREUNDII HIGHLY RESISTANT TO NEW QUINOLONES
    AOYAMA, H
    FUJIMAKI, K
    SATO, K
    FUJII, T
    INOUE, M
    HIRAI, K
    MITSUHASHI, S
    [J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1988, 32 (06) : 922 - 924
  • [2] NORFLOXACIN RESISTANCE IN A CLINICAL ISOLATE OF ESCHERICHIA-COLI
    AOYAMA, H
    SATO, K
    KATO, T
    HIRAI, K
    MITSUHASHI, S
    [J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1987, 31 (10) : 1640 - 1641
  • [3] RELATIONSHIPS AMONG ANTIBACTERIAL ACTIVITY, INHIBITION OF DNA GYRASE, AND INTRACELLULAR ACCUMULATION OF 11-FLUOROQUINOLONES
    BAZILE, S
    MOREAU, N
    BOUZARD, D
    ESSIZ, M
    [J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1992, 36 (12) : 2622 - 2627
  • [4] ACCUMULATION OF ENOXACIN BY ESCHERICHIA-COLI AND BACILLUS-SUBTILIS
    BEDARD, J
    WONG, S
    BRYAN, LE
    [J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1987, 31 (09) : 1348 - 1354
  • [5] FACTORS INFLUENCING THE ACCUMULATION OF CIPROFLOXACIN IN PSEUDOMONAS-AERUGINOSA
    CELESK, RA
    ROBILLARD, NJ
    [J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1989, 33 (11) : 1921 - 1926
  • [6] ROUTES OF QUINOLONE PERMEATION IN ESCHERICHIA-COLI
    CHAPMAN, JS
    GEORGOPAPADAKOU, NH
    [J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1988, 32 (04) : 438 - 442
  • [7] FLEROXACIN RESISTANCE IN ESCHERICHIA-COLI
    CHAPMAN, JS
    BERTASSO, A
    GEORGOPAPADAKOU, NH
    [J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1989, 33 (02) : 239 - 241
  • [8] INVITRO ACTIVITY OF SPARFLOXACIN
    CHIN, NX
    GU, JW
    YU, KW
    ZHANG, YX
    NEU, HC
    [J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1991, 35 (03) : 567 - 571
  • [9] ASSOCIATION BETWEEN EARLY INHIBITION OF DNA-SYNTHESIS AND THE MICS AND MBCS OF CARBOXYQUINOLONE ANTIMICROBIAL AGENTS FOR WILD-TYPE AND MUTANT [GYRA NFXB(OMPF) ACRA] ESCHERICHIA-COLI K-12
    CHOW, RT
    DOUGHERTY, TJ
    FRAIMOW, HS
    BELLIN, FY
    MILLER, MH
    [J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1988, 32 (08) : 1113 - 1118
  • [10] ENDOGENOUS ACTIVE EFFLUX OF NORFLOXACIN IN SUSCEPTIBLE ESCHERICHIA-COLI
    COHEN, SP
    HOOPER, DC
    WOLFSON, JS
    SOUZA, KS
    MCMURRY, LM
    LEVY, SB
    [J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1988, 32 (08) : 1187 - 1191